Early Career
Born in a middle class family on March 11, 1974, Dr. RK is a soft spoken man who excelled in his school education. He did his initial schooling in St. Peters School in Royapuram, Chennai where he ranked school first in his 10th examinations. Later, doing his high school in KC Nadar School in Washermanpet, Chennai, he got selected to pursue his MBBS in Stanley Medical College, Chennai.
College Education
1991 - 1997
Bachelor of Medicine and Bachelor of Surgery (MBBS)
Stanley Medical College and Hospital, Chennai, India
1997 - 2000
Master of Surgery (General Surgery)
Stanley Medical College and Hospital, Chennai, India
2004 - 2005
Fellowship in Podiatric Surgery
Amrita Institute of Medical Sciences, Kochi, India
Our Founder
From the vision of one man, the exclusive hospital for the foot was founded.
When Dr. Rajesh Kesavan started his podiatry practice in 2005, he was the first and only podiatrist in Chennai. He pioneered podiatry field of medicine and has written number of papers and trained other doctors in the field of Podiatry.
Dr. RK got inspired to specialize in Podiatry when he attended a conference in Jaipur conducted by Prof. Arun Bal in 2003. He reached out to Prof. Arun Bal and did a fellowship under him in Podiatric Surgery with special emphasis on Diabetic Foot Surgery. He started his practice as a Podiatrist in 2005 in Kumaran Hospital, Kilpauk, Chennai. He was the first doctor to practice as a Podiatrist in Tamil Nadu.
Dr. RK with Professor Arun Bal
Papers and Publications of Dr. Rajesh Kesavan
miR-23c regulates wound healing by targeting stromal cell-derived factor-1α (SDF-1α/CXCL12) among patients with diabetic foot ulcer
Amin, K. N., Umapathy, D., Anandharaj, A., Ravichandran, J., Sasikumar, C. S., Chandra, S. K. R., Kesavan, R., & Kunka Mohanram, R. (2020, January). miR-23c regulates wound healing by targeting stromal cell-derived factor-1α (SDF-1α/CXCL12) among patients with diabetic foot ulcer. Microvascular Research, 127, 103924. https://doi.org/10.1016/j.mvr.2019.103924.
Circulatory levels of B-cell activating factor of the TNF family in patients with diabetic foot ulcer: Association with disease progression
Dhamodharan, U. et al. (2019) “Circulatory levels of b‐cell activating factor of the TNF family in patients with diabetic foot ulcer: Association with disease progression,” Wound Repair and Regeneration, 27(5), pp. 442–449. Available at: https://doi.org/10.1111/wrr.12720.
Tissue-specific role of Nrf2 in the treatment of diabetic foot ulcers during hyperbaric oxygen therapy
Dhamodharan, U. et al. (2019) “Tissue-specific role of Nrf2 in the treatment of diabetic foot ulcers during hyperbaric oxygen therapy,” Free Radical Biology and Medicine, 138, pp. 53–62. Available at: https://doi.org/10.1016/j.freeradbiomed.2019.04.031.
Guidance for Diabetic Foot Management during COVID‑19 Pandemic
Kesavan, R. et al. (2020) “Guidance for diabetic foot management during COVID-19 pandemic,” Indian Journal of Vascular and Endovascular Surgery, 7(2), p. 116. Available at: https://doi.org/10.4103/ijves.ijves_43_20.
Onychocryptosis complicated with osteomyelitis – A case report from tertiary wound care centre in South India
Kesavan, R., Sasi kumar, C.S. and Gandeban, A. (2020) “Onychocryptosis complicated with osteomyelitis – a case report from Tertiary Wound Care Center in south india,” Indian Journal of Case Reports, 6(9), pp. 523–525. Available at: https://doi.org/10.32677/ijcr.2020.v06.i09.014.
Management of Diabetic Foot Ulcer with MA–ECM (Minimally Manipulated Autologous Extracellular Matrix) Using 3D Bioprinting Technology – An Innovative Approach
Kesavan, R., Sheela Sasikumar, C., Narayanamurthy, V. B., Rajagopalan, A., & Kim, J. (2021). Management of diabetic foot ulcer with ma–ECM (minimally manipulated autologous extracellular matrix) using 3D bioprinting technology – an innovative approach. The International Journal of Lower Extremity Wounds, 153473462110456. https://doi.org/10.1177/15347346211045625.
Efficacy of Oral Protein Supplementation “PRO 360 Diabetic” on Diabetic Foot Ulcer Patients-A Pilot study
Kesavan, R., Sheela Sasikumar, C. and Thirunawkkarasu, Y. (2020) “Efficacy of oral protein supplementation ‘pro 360 diabetic’ on diabetic foot ulcer patients-a pilot study,” Journal of Food Science and Nutrition Research, 03(03). Available at: https://doi.org/10.26502/jfsnr.2642-11000049.
Gene expression profiling of multiple histone deacetylases (HDAC) and its correlation with NRF2-mediated redox regulation in the pathogenesis of diabetic foot ulcers
Teena, R. et al. (2020) “Gene expression profiling of multiple histone deacetylases (HDAC) and its correlation with NRF2-mediated redox regulation in the pathogenesis of diabetic foot ulcers,” Biomolecules, 10(10), p. 1466. Available at: https://doi.org/10.3390/biom10101466.
Analysis of the Exonic Single Nucleotide Polymorphism rs182428269 of the NRF2 Gene in Patients with Diabetic Foot Ulcer
Teena, R. et al. (2021) “Analysis of the exonic single nucleotide polymorphism RS182428269 of the NRF2 gene in patients with diabetic foot ulcer,” Archives of Medical Research, 52(2), pp. 224–232. Available at: https://doi.org/10.1016/j.arcmed.2020.10.011.
Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers
Umapathy, D. et al. (2018) “Potential of circulatory procalcitonin as a biomarker reflecting inflammation among south Indian diabetic foot ulcers,” Journal of Vascular Surgery, 67(4). Available at: https://doi.org/10.1016/j.jvs.2017.02.060.
A pilot study on the effects of a polyherbal formulation cream on diabetic foot ulcers
Viswanathan, V. et al. (2016) “Effect of a polyherbal formulation cream on diabetic neuropathic pain among patients with type 2 diabetes - a pilot study,” Indian Journal of Medical Research, 144(2), p. 215. Available at: https://doi.org/10.4103/0971-5916.195033.
Dr. RK with Prof. Arun Bal, Prof. Christopher Attinger and Prof. David Armstrong
